Do I need a dose change: how to talk to your doctor about this

Recognizing When a Dose Change May Be Needed

As the founder of CFP Weight Loss and author of The CFP Method, I’ve guided thousands of patients aged 45-54 through the realities of GLP-1 medications like semaglutide and tirzepatide. Many hit a plateau between months 3-6, especially when hormonal shifts during perimenopause or menopause slow metabolism further. Common signals include stalled scale movement for 4+ weeks despite consistent calorie deficit, returning hunger cues, or insulin resistance symptoms worsening despite diabetes management.

Joint pain often limits exercise, making medication optimization even more critical. Insurance hurdles add stress, yet the right conversation can secure coverage for dose titration without out-of-pocket surprises.

Preparing for the Conversation

Before your appointment, track three key metrics for at least two weeks: daily weight (same time, fasted), hunger and satiety levels on a 1-10 scale, and side effects such as nausea or constipation. Note blood glucose readings if managing diabetes or blood pressure. Bring a one-page summary—doctors appreciate concise data. Review your GLP-1 titration schedule from The CFP Method, which emphasizes gradual increases to minimize GI distress while maximizing fat loss.

Anticipate questions: “What’s your current dose and how long have you been on it?” Prepare to discuss lifestyle factors. Many beginners feel embarrassed about obesity, but framing it as “I’m committed to the CFP approach and want to troubleshoot this plateau” builds partnership.

Scripts and Questions That Work

Use this opener: “I’ve followed the nutrition and movement guidelines from The CFP Method but my progress has stalled for five weeks. My hunger has returned and the scale hasn’t moved. Could we discuss whether a dose increase from 1.0 mg to 1.7 mg of semaglutide makes sense given my labs?”

Ask targeted questions: “Based on my current insulin sensitivity markers, would a higher dose improve satiety without increasing side effects?” “What titration schedule do you recommend to stay within insurance guidelines?” “Are there blood tests we should run first?” If joint pain limits activity, mention: “Low-impact movement is challenging—optimizing the medication could help me build momentum.”

If your doctor hesitates, request a 4-week trial at the new dose with follow-up labs. This data-driven approach often sways coverage decisions.

After the Visit: Monitoring and Adjusting

Once approved, follow the exact titration steps in The CFP Method: increase by 0.25–0.5 mg every 7–14 days while logging symptoms. Most patients notice renewed appetite control within 10 days. Schedule a 3-week check-in to review progress and blood pressure. If side effects intensify, having a clear reduction plan prevents discouragement.

Remember, successful long-term weight management in midlife requires both pharmacology and the sustainable habits outlined in the CFP program. Clear doctor communication turns hesitation into a collaborative success story.